Researchers have discovered that breast tumors can boost their growth by recruiting stromal cells originally formed in the bone marrow. The study reveals that the recruitment of bone marrow-derived fibroblasts lowers the odds of surviving breast cancer, but suggests that targeting these cells could be an effective way of treating the disease.